Clinical Trial Update: Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.

View source ↗

Summary

This clinical trial investigates how primary and secondary HIV drug-resistance mutations (DRMs) may predict failure of antiretroviral therapy. It includes evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Medical University of Warsaw | Conditions: HIV-1-infection, DRM | Status: NOT_YET_RECRUITING